share_log

華領醫藥-B:董事會召開日期

HUA MEDICINE-B: Date of Board Meeting

HKEX ·  Aug 19 16:30

Summary by Futu AI

華領醫藥-B(2552)宣布,將於2024年8月29日(星期四)召開董事會會議。會議的主要目的是考慮及通過集團截至2024年6月30日止六個月的中期業績報告及相關公告。此外,會議還將處理其他事務。該通知由行政總裁兼執行董事陳力博士於2024年8月19日發出。
華領醫藥-B(2552)宣布,將於2024年8月29日(星期四)召開董事會會議。會議的主要目的是考慮及通過集團截至2024年6月30日止六個月的中期業績報告及相關公告。此外,會議還將處理其他事務。該通知由行政總裁兼執行董事陳力博士於2024年8月19日發出。
Huaying Medicine-B (2552) announced that it will hold a board of directors meeting on Thursday, August 29, 2024. The main purpose of the meeting is to consider and approve the group's interim performance report and related announcements for the six months ended June 30, 2024. In addition, the meeting will also handle other matters. The notice was issued by Dr. Chen Li, CEO and executive director, on August 19, 2024.
Huaying Medicine-B (2552) announced that it will hold a board of directors meeting on Thursday, August 29, 2024. The main purpose of the meeting is to consider and approve the group's interim performance report and related announcements for the six months ended June 30, 2024. In addition, the meeting will also handle other matters. The notice was issued by Dr. Chen Li, CEO and executive director, on August 19, 2024.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.